My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 327

    1.

    BiDil for heart failure in black patients: implications of the U.S. Food and Drug Administration approval.

    Bibbins-Domingo K, Fernandez A.

    Ann Intern Med. 2007 Jan 2;146(1):52-6. Erratum in: Ann Intern Med. 2007 Apr 17;146(8):616. PMID: 17200222 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    BiDil for heart failure in black patients: The U.S. Food and Drug Administration perspective.

    Temple R, Stockbridge NL.

    Ann Intern Med. 2007 Jan 2;146(1):57-62.PMID: 17200223 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Flaws in the U.S. Food and Drug Administration's rationale for supporting the development and approval of BiDil as a treatment for heart failure only in black patients.

    Ellison GT, Kaufman JS, Head RF, Martin PA, Kahn JD.

    J Law Med Ethics. 2008 Fall;36(3):449-57.PMID: 18840235 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    BiDil for heart failure in black patients.

    Kahn JD.

    Ann Intern Med. 2007 Aug 7;147(3):215; author reply 215-6. No abstract available. PMID: 17679713 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    BiDil for heart failure in black patients.

    Bibbins-Domingo K, Fernandez A.

    Ann Intern Med. 2007 Aug 7;147(3):214-5; author reply 215-6. No abstract available. PMID: 17679712 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    FDA approves heart drug for black patients.

    Meadows M.

    FDA Consum. 2005 Sep-Oct;39(5):8-9.PMID: 16419285 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    U.S. to review drug intended for one race.

    Saul S.

    NY Times (Print). 2005 Jun 13:A1, A15. No abstract available. PMID: 15966118 [PubMed - indexed for MEDLINE]Related articles

    8.

    Misreading race and genomics after BiDil.

    Kahn J.

    Nat Genet. 2005 Jul;37(7):655-6. No abstract available. PMID: 15990879 [PubMed - indexed for MEDLINE]Related articles

    9.

    Bidil: recontextualizing the race debate.

    Séguin B, Hardy B, Singer PA, Daar AS.

    Pharmacogenomics J. 2008 Jun;8(3):169-73. Epub 2008 Jan 15. No abstract available. PMID: 18195727 [PubMed - indexed for MEDLINE]Related articles

    10.

    Race-based therapeutics.

    Bloche MG.

    N Engl J Med. 2004 Nov 11;351(20):2035-7. Epub 2004 Nov 8. No abstract available. PMID: 15533852 [PubMed - indexed for MEDLINE]Related articles

    11.

    Prescribing BiDil: is it black and white?

    Haga SB, Ginsburg GS.

    J Am Coll Cardiol. 2006 Jul 4;48(1):12-4. Epub 2006 Jun 9.PMID: 16814642 [PubMed - indexed for MEDLINE]Related articles

    12.

    "Ethnic drugs".

    Kahn J.

    Hastings Cent Rep. 2005 Jan-Feb;35(1):1 p following 48. No abstract available. PMID: 15799501 [PubMed - indexed for MEDLINE]Related articles

    13.

    Gray area for new heart failure drug. Although the FDA approved BiDil for blacks with heart failure, it may work in anyone.

    [No authors listed]

    Harv Heart Lett. 2005 Nov;16(3):1-2. No abstract available. PMID: 16363036 [PubMed - indexed for MEDLINE]Related articles

    14.

    The paradox of race in the Bidil debate.

    Crawley L.

    J Natl Med Assoc. 2007 Jul;99(7):821-2. No abstract available. PMID: 17668653 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    BiDil: assessing a race-based pharmaceutical.

    Brody H, Hunt LM.

    Ann Fam Med. 2006 Nov-Dec;4(6):556-60.PMID: 17148635 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Race-based medicine and justice as recognition: exploring the phenomenon of BiDil.

    Yu JH, Goering S, Fullerton SM.

    Camb Q Healthc Ethics. 2009 Winter;18(1):57-67. No abstract available. PMID: 19091146 [PubMed - indexed for MEDLINE]Related articles

    17.

    BiDil (isosorbide dinitrate and hydralazine): a new fixed-dose combination of two older medications for the treatment of heart failure in black patients.

    Carmody MS, Anderson JR.

    Cardiol Rev. 2007 Jan-Feb;15(1):46-53. Review.PMID: 17172884 [PubMed - indexed for MEDLINE]Related articles

    18.

    Using race in clinical research to develop tailored medications. Is the FDA encouraging discrimination or eliminating traditional disparities in health care for African Americans?

    Ruel MD.

    J Leg Med. 2006 Jun;27(2):225-41. No abstract available. PMID: 16728354 [PubMed - indexed for MEDLINE]Related articles

    19.

    Race, pharmacogenomics, and marketing: putting BiDil in context.

    Kahn J.

    Am J Bioeth. 2006 Sep-Oct;6(5):W1-5.PMID: 16997802 [PubMed - indexed for MEDLINE]Related articles

    20.

    BiDil: from another vantage point.

    Puckrein G.

    Health Aff (Millwood). 2006 Sep-Oct;25(5):w368-74. Epub 2006 Aug 15.PMID: 16912053 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity